Results 51 to 60 of about 10,746 (218)
Drug Design, Development and Therapy, 2014 Maria Vittoria Cossu,1 Dario Cattaneo,1 Serena Fucile,1 Paolo Pellegrino,1 Sara Baldelli,1 Valeria Cozzi,1 Amedeo Capetti,2 Emilio Clementi1,3 1Unit of Clinical Pharmacology, Consiglio Nazionale delle Ricerche Institute of Neuroscience, Department of ...
Cossu MV +7 more
doaj
Race, Money and Medicines [PDF]
, 2006 Taking notice of race is both risky and inevitable, in medicine no less than in other endeavors. The literature on race as a classifying tool in clinical research poses this core dilemma: On the one hand, race can be a useful stand-in for unstudied ...
Bloche, Maxwell Gregg
core +1 more source
Clinical Pharmacology &Therapeutics, Volume 118, Issue 6, Page 1430-1436, December 2025.Hydralazine is a vasodilator typically used in the treatment of resistant hypertension and heart failure. N‐acetyltransferase 2 (NAT2) catalyzes the metabolism of hydralazine into inactive metabolites. NAT2 poor metabolizers (historically referred to as “slow acetylators”) are predicted to have increased plasma hydralazine concentrations compared with ...
Michael T. Eadon +18 more
wiley +1 more source
Journal of Pharmacological Sciences, 2012 Vasorelaxant properties of N-2-(ferulamidoethyl)-nitrate (ferulate nitrate, FLNT), a newly synthesized nitrate, were compared with those of isosorbide dinitrate, nicorandil, nitroglycerin, and 8-bromoguanosine 3,5-cyclic monophosphate (8-Br-cGMP) in rat ...
Zhan-Qing Wang +4 more
doaj +1 more source
Drug-Induced Hemolysis in G6PD Deficiency: an Unusual Presentation of a Common Clinical Condition
Acta Medica, 2020 Glucose-6-phosphate dehydrogenase (G6PD) deficiency can present a diagnostic dilemma owing to the varying degrees of disease severity and the wide range of precipitating factors.
Anudeep Padakanti +3 more
doaj +1 more source
The importance of excluding coronary artery vasospasm before percutaneous transluminal coronary angioplasty. A case report [PDF]
, 1986 CITATION: Przybojewski, J. Z. 1986.The importance of excluding coronary artery vasospasm before percutaneous transluminal coronary angioplasty. A case report.
Przybojewski, J. Z.
core
For Vol.70, No.5 pp405-408 A Multicenter, Prospective, Randomized Controlled Trial Evaluating the Efficacy of Rectal Diclofenac and Sublingual Nitrate as a Combined Prophylactic Treatment for Post-ERCP Pancreatitis [PDF]
, 2016 In the article by Tomoda T et al. entitled “A Multicenter, Prospective, Randomized Controlled Trial Evaluating the Efficacy of Rectal Diclofenac and Sublingual Nitroglycerin as a Combined Prophylactic Treatment for Post-ERCP Pancreatitis”, which appeared
Akimoto, Yutaka +10 more
core +1 more source
European Journal of Heart Failure, Volume 27, Issue 12, Page 2671-2690, December 2025.Main categories of harmful drugs in heart failure. CCB, calcium channel blocker; DPP4i, dipeptidyl peptidase‐4 inhibitor; HER2‐TT, human epidermal growth factor receptor 2‐targeted therapy; NSAID, non‐steroidal anti‐inflammatory drug; TKI, tyrosine kinase inhibitor; TZD, thiazolidinedione; VEGF Inh, vascular endothelial growth factor inhibitor.
Amr Abdin +16 more
wiley +1 more source
Journal of Pharmacological Sciences, 2011 .: To investigate the effect of hypoxia or hypoxia/reoxygenation on vascular smooth muscle function, mechanical response of monkey coronary artery without endothelium was studied under normoxia, hypoxia, and hypoxia/reoxygenation.
Masashi Tawa +6 more
doaj +1 more source
Evaluasi Penggunaan Obat Pada Pasien Gagal Jantung Rawat Inap Di Rumah Sakit “X” Tahun 2016 [PDF]
, 2018 Heart failure is inability of the heart to pump blood containing oxygen and nutrition sufficiently to meet the needs of body tissues. Purpose of the research was to know appropriateness of heart failure therapy consisting of appropriate indication ...
, Ambar Yunita Nugraheni, M.Sc., Apt. +1 more
core